title: Apurinic/apyrimidinic endonuclease 1 is the essential nuclease during immunoglobulin class switch recombination.
abstract: Immunoglobulin (Ig) class switch recombination (CSR) is initiated by activation-induced cytidine deaminase (AID) that catalyzes numerous DNA cytosine deaminations within switch regions. The resulting uracils are processed by uracil base excision and/or mismatch repair enzymes that ultimately generate switch region DNA double-strand breaks (DSBs). Uracil glycosylase 2 (UNG2) is required for CSR, most likely by removing uracils to generate abasic sites. Although it is presumed that the apurinic/apyrimidinic endonuclease 1 (APE1) generates DNA strand incisions (a prerequisite for CSR) at these abasic sites, a direct test of the requirement for APE1 in CSR has been difficult because of the embryonic lethality of APE1 ablation in mice. Here, we report the successful deletion of the APE1 gene in a mouse B cell line (CH12F3) capable of robust CSR in vitro. In contrast to the general assumption that APE1 is essential for cellular viability, deletion of APE1 in CH12F3 cells has no apparent effect on cell viability or growth. Moreover, CSR in APE1-null CH12F3 cells is drastically reduced, providing direct evidence for an essential role for APE1 in switch region cleavage and CSR. Finally, deletion of AP endonuclease 2 (APE2) has no effect on CSR in either APE1-proficient or -deficient cells.
authors: Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA.
authors: Shahnaz
authors: S
authors: Masani
authors: Li
authors: L
authors: Han
authors: Kefei
authors: K
authors: Yu
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000378:metabolism; D002460:Cell Line; D002470:Cell Survival / Q000235:genetics; D003564:Cytidine Deaminase / Q000235:genetics / Q000378:metabolism; D004247:DNA / Q000235:genetics; D053903:DNA Breaks, Double-Stranded; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase / Q000235:genetics* / Q000378:metabolism*; D004720:Endonucleases / Q000235:genetics / Q000378:metabolism; D017578:Immunoglobulin Class Switching / Q000235:genetics*; D051379:Mice; D064251:Multifunctional Enzymes; D011995:Recombination, Genetic; D014498:Uracil / Q000378:metabolism; D051981:Uracil-DNA Glycosidase / Q000235:genetics / Q000378:metabolism
chemical_list: D064251:Multifunctional Enzymes; D014498:Uracil; D004247:DNA; C476886:Apex2 protein, mouse; D004720:Endonucleases; D051981:Uracil-DNA Glycosidase; D003564:Cytidine Deaminase; C486216:Apex1 protein, mouse; D043603:DNA-(Apurinic or Apyrimidinic Site) Lyase
references: Mol Cell. 2005 Feb 4;17(3):463-70
references: 15694346
references: Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4604-8
references: 22392994
references: Nucleic Acids Res. 2006 May 10;34(9):2508-15
references: 16687656
references: Nature. 2002 Jul 4;418(6893):99-103
references: 12097915
references: Annu Rev Biochem. 1994;63:915-48
references: 7979257
references: Nat Immunol. 2004 Feb;5(2):224-9
references: 14716311
references: Int Immunol. 2009 Aug;21(8):947-55
references: 19556307
references: Curr Biol. 2002 Oct 15;12(20):1748-55
references: 12401169
references: Int Immunol. 2010 Mar;22(3):213; author reply 213-4
references: 20185435
references: J Immunol. 2010 Aug 1;185(3):1379-81
references: 20585033
references: Adv Immunol. 2005;87:297-328
references: 16102577
references: EMBO J. 1999 Jun 15;18(12):3484-90
references: 10369687
references: J Exp Med. 2005 Jun 20;201(12):1885-90
references: 15955838
references: Cell. 2006 Jul 28;126(2):297-308
references: 16873062
references: Mol Cell. 2004 Oct 22;16(2):163-71
references: 15494304
references: Nat Immunol. 2011 Jan;12(1):70-6
references: 21151102
references: Genomics. 2003 Jan;81(1):47-57
references: 12573260
references: Cell. 2000 Sep 1;102(5):553-63
references: 11007474
references: Nat Rev Immunol. 2004 Jul;4(7):541-52
references: 15229473
references: DNA Repair (Amst). 2003 Nov 21;2(11):1163-74
references: 14599739
references: Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11584-9
references: 21709240
references: Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):8919-23
references: 8799128
references: Environ Mol Mutagen. 2000;36(4):312-24
references: 11152564
references: Oncogene. 2002 Dec 16;21(58):8935-48
references: 12483510
references: Immunity. 2003 Oct;19(4):515-24
references: 14563316
references: Science. 2004 Aug 20;305(5687):1160-3
references: 15326357
references: Mutat Res. 1998 Oct 21;409(1):17-29
references: 9806499
references: J Clin Invest. 2003 Jul;112(1):136-42
references: 12840068
references: J Exp Med. 2007 Nov 26;204(12):3017-26
references: 18025127
references: Cell. 2000 Sep 1;102(5):565-75
references: 11007475
references: J Exp Med. 2007 Dec 24;204(13):3209-19
references: 18070939
references: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2752-7
references: 19202054
references: J Exp Med. 2008 Nov 24;205(12):2745-53
references: 19001141
references: Cancer Res. 2001 Jul 15;61(14):5552-7
references: 11454706
references: Proc Natl Acad Sci U S A. 2005 Apr 19;102(16):5739-43
references: 15824325